Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor
- 15 October 2009
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 114 (16), 3489-3496
- https://doi.org/10.1182/blood-2008-10-184317
Abstract
Investigation of 3 families with bleeding symptoms demonstrated a defect in the collagen-binding activity of von Willebrand factor (VWF) in association with a normal VWF multimeric pattern. Genetic analysis showed affected persons to be heterozygous for mutations in the A3 domain of VWF: S1731T, W1745C, and S1783A. One person showed compound heterozygosity for W1745C and R760H. W1745C and S1783A have not been reported previously. The mutations were reproduced by site-directed mutagenesis and mutant VWF expressed in HEK293T cells. Collagen-binding activity measured by immunosorbent assay varied according to collagen type: W1745C and S1783A were associated with a pronounced binding defect to both type I and type III collagen, whereas the principal abnormality in S1731T patients was a reduction in binding to type I collagen only. The multimer pattern and distribution of mutant proteins were indistinguishable from wild-type recombinant VWF, confirming that the defect in collagen binding resulted from the loss of affinity at the binding site and not impairment of high-molecular-weight multimer formation. Our findings demonstrate that mutations causing an abnormality in the binding of VWF to collagen may contribute to clinically significant bleeding symptoms. We propose that isolated collagen-binding defects are classified as a distinct subtype of von Willebrand disease.This publication has 25 references indexed in Scilit:
- Generation and validation of the Condensed MCMDM‐1VWD Bleeding Questionnaire for von Willebrand diseaseJournal of Thrombosis and Haemostasis, 2008
- Altered thrombus formation in von Willebrand factor–deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIaBlood, 2008
- N-linked glycosylation of VWF modulates its interaction with ADAMTS13Blood, 2008
- An Update on the von Willebrand Factor Collagen Binding Assay: 21 Years of Age and Beyond Adolescence but Not Yet a Mature AdultSeminars in Thrombosis and Hemostasis, 2007
- von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagenJournal of Thrombosis and Haemostasis, 2006
- New light on an old story: von Willebrand factor binding to collagenJournal of Thrombosis and Haemostasis, 2006
- A Consensus Tetrapeptide Selected by Phage Display Adopts the Conformation of a Dominant Discontinuous Epitope of a Monoclonal Anti-VWF Antibody That Inhibits the von Willebrand Factor-Collagen InteractionOnline Journal of Public Health Informatics, 2003
- Mapping the Collagen-binding Site in the von Willebrand Factor-A3 DomainOnline Journal of Public Health Informatics, 2003
- An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variantBlood, 2003
- Collagen-binding mode of vWF-A3 domain determined by a transferred cross-saturation experimentNature Structural & Molecular Biology, 2002